Terms ending in 2035
Every in-force patent on MiMedx Group, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,842,824 | Method for Inducing Angiogenesis In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 10,052,351 | Method for Inducing Angiogenesis In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 10,449,220 | Micronized Placental Compositions Comprising a Chelator In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 12,076,348 | Micronized Placental Compositions Comprising a Chelator In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 10,307,443 | Micronized Wharton's Jelly In force · Low confidence | MiMedx Group, Inc. | In force | Low confidence | |
| US 10,617,785 | Collagen Reinforced Tissue Grafts In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 10,143,777 | Fenestration Kits for Making Fenestrated Placental Tissue Allografts and Methods of Using the Same In force · High confidence | MiMedx Group, Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.